Sharper gene scissors for the biotechnology toolbox

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...
Labroots

Beyond CRISPR Basics: Molecular Biology Innovations in Cell Engineering

Beginning with a brief historical overview of CRISPR, we will trace its evolution to the current state of gene engineering, highlighting its pivotal role in reshaping the landscape of molecular ...
Scientific American

FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease

CRISPR, the gene-editing technology that has revolutionized biological research, is finally available as a medical treatment with regulatory approval. On December 8 the U.S. Food and Drug ...
Nature

CRISPR-Editing

The Nobel Prize in Chemistry was awarded to Dr. Charpentier and Dr. Doudna for the development of the CRISPR/Cas9 genetic scissors in 2020. CRISPR, a genome-editing tool, allows scientists to modify ...
STAT

Parents of children with rare diseases ask: How long until our CRISPR miracle?

In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...
FiercePharma

Vertex, CRISPR's gene-editing therapy Casgevy wins early FDA nod to treat beta thalassemia

Vertex Pharmaceuticals and CRISPR Therapeutics have scored an FDA approval for their gene-editing therapy Casgevy (exa-cel) to treat transfusion-dependent beta thalassemia (TDT). The approval comes ...